Psychiatric NP Scope of Practice for Insomnia in New York

If you’re a psychiatrist or PMHNP considering telehealth for insomnia care—or already doing it—you’ve probably asked yourself: Can I legally prescribe sleep medications through a video visit?

The short answer in 2026: Yes, you can prescribe controlled insomnia medications via telehealth, thanks to federal extensions that remain in effect through December 31, 2026. But the details matter—a lot. Federal DEA rules, state telehealth laws, and your scope of practice all intersect in ways that can either open doors or create landmines.

This guide breaks down what you need to know: current DEA rules, how insomnia medications are regulated, scope differences between psychiatrists and PMHNPs, and state-by-state requirements in California, Texas, Florida, New York, Pennsylvania, and Illinois.

The Federal Picture: DEA Telehealth Rules for Controlled Substances

Where We Stand Now (2026)

The COVID-19 pandemic forced the DEA to waive the Ryan Haight Act’s in-person exam requirement for prescribing controlled substances via telehealth. That flexibility has been extended four times—most recently through December 31, 2026.

Here’s what this means practically: You can prescribe Schedule II–V controlled substances (including common insomnia meds like zolpidem, eszopiclone, and temazepam) to new patients via live audio-video telehealth without ever seeing them in person—as long as you meet the standard of care and comply with state law.

This is huge. Before 2020, the Ryan Haight Act effectively banned telehealth prescribing of controlled substances without at least one in-person visit. That law was designed to stop internet pill mills, but it also blocked legitimate telehealth care. The temporary waivers changed everything.

What’s Coming: Permanent DEA Telehealth Rules

The DEA is working on permanent regulations to replace these temporary extensions. In January 2025, they announced a proposed framework featuring:

• Special Registration for Telemedicine: Any DEA-registered provider could apply for this to prescribe Schedule III–V controlled substances via telehealth without in-person exams
• Advanced Telemedicine Registration: Reserved for certain specialists (including psychiatrists) to prescribe Schedule II substances via telehealth, with national PDMP safeguards

For insomnia providers, this is mostly good news. Most sleep medications are Schedule IV (zolpidem, eszopiclone, benzodiazepines). Under the proposed rules, you’d likely need a special registration but could continue telehealth prescribing.

The catch: These rules aren’t finalized yet. The DEA extended temporary flexibilities through 2026 to avoid disrupting care while they work out the details. Keep an eye out for the final rule, expected before 2027.

What This Means for Your Practice

Right now, you can prescribe insomnia medications via telehealth under federal law if:

• You conduct a proper telehealth evaluation (video preferred; audio-only allowed for certain addiction treatments)
• The prescription is for a legitimate medical purpose
• You have a valid DEA registration
• You comply with your state’s laws (more on this below)

Document thoroughly. Standard of care via telehealth should equal in-person care: sleep history, medical screening (rule out apnea, medication interactions, psychiatric comorbidities), and justification for the medication choice.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Insomnia Medications: What Schedule Are They?

Understanding how insomnia drugs are classified helps you navigate the rules.

Schedule IV (most common insomnia medications):

• Z-drugs: Zolpidem (Ambien), eszopiclone (Lunesta), zaleplon
• Benzodiazepines: Temazepam (Restoril), triazolam
• Orexin antagonists: Suvorexant (Belsomra), lemborexant

All carry some risk of dependence, hence the Schedule IV classification. But they’re considered lower-risk than Schedule II opioids or stimulants.

Non-controlled options:

• Trazodone (antidepressant used off-label)
• Doxepin (low-dose antidepressant)
• Ramelteon (melatonin receptor agonist)
• Over-the-counter antihistamines

If you can manage a patient’s insomnia with non-controlled medications, you avoid the regulatory overhead entirely. But when patients need more aggressive treatment, controlled substances are often necessary—and that’s where telehealth rules kick in.

Schedule II substances (rarely used for insomnia):Sodium oxybate (Xyrem) for narcolepsy is Schedule III. Some providers might consider stimulants for hypersomnia, but that’s a different clinical picture. For primary insomnia, you’re almost always dealing with Schedule III–V.

Practical Prescribing Considerations

When prescribing controlled insomnia medications via telehealth:

1. Check your state’s PDMP before every prescription. Many states legally require this for Schedule IV substances—Texas, Pennsylvania, and New York mandate checks for benzodiazepines; California requires checks for all Schedule II–IV before the first prescription and every four months thereafter.

2. Use electronic prescribing. Most states now require EPCS (Electronic Prescribing for Controlled Substances) for Schedule II–V medications. Paper scripts for controlled substances are largely obsolete.

3. Start conservatively. Lowest effective dose, shortest reasonable duration. This protects patients and keeps you on the right side of medical board scrutiny.

4. Document thoroughly. Your chart should show why you chose this medication, why behavioral interventions alone weren’t sufficient (or are being tried concurrently), and your monitoring plan.

5. Educate patients about dependence risk, especially with benzodiazepines. Some state boards expect you to discuss non-pharmacologic options (like CBT-I) even if you’re primarily a medication manager.

Psychiatrist vs. PMHNP: Scope of Practice for Insomnia

Psychiatrists: Full Authority, Fewer Barriers

If you’re a psychiatrist (MD/DO), treating insomnia is squarely within your scope in every state. You can:

• Diagnose and treat insomnia independently
• Prescribe any medication (controlled or not) without supervision
• Provide psychotherapy (like CBT-I) if trained
• Practice via telehealth anywhere you hold a medical license

No state restricts psychiatrists from managing insomnia. Your biggest regulatory hurdles are state licensure (no universal medical license compact coverage in all states) and complying with controlled substance laws (DEA registration, state CS license, PDMP checks).

One advantage: Under the proposed DEA rules, psychiatrists would qualify for Advanced Telemedicine Registration, allowing Schedule II prescribing via telehealth. While insomnia rarely requires Schedule II drugs, this flexibility matters if you’re treating comorbid ADHD or narcolepsy.

PMHNPs: Scope Varies Dramatically by State

Psychiatric-Mental Health Nurse Practitioners are vital to expanding access to insomnia care—but your practice authority depends entirely on where your patients are located.

Full Practice Authority states (for experienced NPs):

• New York: After 3,600 hours of supervised practice, PMHNPs can practice and prescribe independently
• Illinois: After 4,000 hours and additional training, NPs can obtain Full Practice Authority, including independent controlled substance prescribing
• California: AB 890 created a pathway for experienced NPs (3+ years in group practice) to practice fully independently

In these states, you can run a solo telehealth insomnia practice, prescribe Schedule IV sleep meds, and build your own patient panel—no physician oversight required.

Reduced Practice states:

• Pennsylvania: PMHNPs need a collaborative agreement with a physician to prescribe. The physician doesn’t co-sign every script, but you must have an agreement on file and the physician reviews your charts periodically.

Restricted Practice states:

• Texas: NPs must have a supervising physician with a written Prescriptive Authority Agreement. Texas also prohibits NPs from prescribing Schedule II controlled substances in outpatient settings—though this doesn’t affect most insomnia care (Schedule IV).
• Florida: PMHNPs require a supervising physician protocol. Florida created an ‘autonomous APRN’ license in 2020, but excluded psychiatric NPs—only certain primary care NPs can practice independently. (Legislation to change this for psych NPs was proposed in 2025 but hasn’t passed yet.)

The Business Reality for NPs

If you’re a PMHNP in Texas or Florida, you can absolutely provide telehealth insomnia care—but you need a collaborating physician. This affects how you structure your practice:

• Employment model: Many NPs join telehealth companies (like Klarity) where the physician collaboration is handled for you. You see patients, prescribe within your scope, and the company manages the regulatory framework.
• Independent practice: Harder in restricted states. You’ll need to recruit a collaborating physician, negotiate an agreement, and ensure they’re comfortable with your patient volume and prescribing patterns.

In Full Practice states like New York or Illinois, experienced NPs have much more autonomy. You can contract directly with telehealth platforms or build your own practice without physician oversight—assuming you meet the experience thresholds and have your FPA license/certification.

State-by-State Telehealth Prescribing Rules for Insomnia

California: Permissive, but Schedule II Caution

Licensing: Must hold a California license (physicians, NPs, or psychologists). No special telehealth license. California is not in the Interstate Medical Licensure Compact, so out-of-state psychiatrists must go through the full CA licensure process.

NP Scope: California’s AB 890 (implemented 2023) allows experienced NPs to practice independently after three years in group settings. PMHNPs with this ‘104 NP’ status can manage insomnia solo, prescribing Schedule IV sleep meds without physician oversight.

Telehealth Prescribing: California allows telehealth prescribing of controlled substances for insomnia (Schedule III–V) with no state-specific restrictions beyond meeting the standard of care. However, California unofficially discourages prescribing Schedule II controlled substances via telehealth without an in-person exam (legacy concerns about pill mills). This doesn’t affect insomnia care—Schedule II isn’t typically used for sleep.

PDMP: Mandatory CURES check before the first prescription of any Schedule II–IV controlled substance, then at least every four months if therapy continues.

E-Prescribing: Required for all controlled substances (since 2022).

Bottom Line: California is telehealth-friendly. If you’re licensed there, you can prescribe insomnia medications via video visits. Just run your PDMP checks and document appropriately.

Texas: Open for Insomnia, Closed for Pain

Licensing: Texas is in the Interstate Medical Licensure Compact (physicians) and the Nurse Licensure Compact (RNs), but APRNs need a full Texas license.

NP Scope: Restricted practice. PMHNPs must have a Prescriptive Authority Agreement with a Texas physician. Texas NPs cannot prescribe Schedule II controlled substances in outpatient settings—period. For insomnia (Schedule IV), NPs can prescribe under physician delegation.

Telehealth Prescribing: Texas reformed its telehealth laws in 2017 (SB 1107), making it much easier to establish a patient relationship via video. You can prescribe controlled substances via telehealth except for chronic pain management.

This is critical: Texas law prohibits using telemedicine to treat chronic pain with controlled substances. But insomnia is not chronic pain, so you’re in the clear. A Texas provider can legally prescribe benzodiazepines or Z-drugs for sleep via telehealth as long as it’s documented as insomnia treatment, not pain management.

PDMP: Required check before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol (muscle relaxant). As of 2021, Texas added all Schedule III–V drugs to the check requirement, so zolpidem now triggers a mandatory PDMP query.

E-Prescribing: Mandatory for all controlled substances (since 2021).

Bottom Line: Texas is workable if you’re treating insomnia (not pain). Psychiatrists have full authority; PMHNPs need physician collaboration. Document clearly that you’re managing a sleep disorder, not chronic pain.

Florida: Psychiatric Exception Is Key

Licensing: Florida offers a unique Out-of-State Telehealth Provider Registration that lets non-Florida-licensed providers practice telehealth in FL without full licensure (must hold an unrestricted license in another state). This is rare and valuable for multi-state practices.

NP Scope: Restricted for psychiatric NPs. Florida’s 2020 ‘Autonomous APRN’ law allows independence for certain primary care NPs, but psychiatric NPs were excluded. PMHNPs still need a supervising physician protocol. (Pending legislation to change this, but not law yet as of 2026.)

Telehealth Prescribing: Here’s where it gets tricky. Florida law prohibits prescribing controlled substances via telehealth except in four scenarios:

1. Treatment of a psychiatric disorder
2. Inpatient hospital care
3. Hospice care
4. Nursing home residents

Insomnia qualifies as a psychiatric disorder (DSM-5: Insomnia Disorder), so you can prescribe Schedule IV sleep medications via telehealth in Florida as long as you document it as psychiatric treatment. This is the loophole that makes telehealth insomnia care legal in FL.

A pain clinic couldn’t prescribe opioids via telehealth in Florida. A weight-loss clinic couldn’t prescribe phentermine (Schedule IV stimulant) via telehealth. But a psychiatrist or PMHNP treating insomnia as a mental health condition? Fully legal under the psychiatric exception.

PDMP: Mandatory E-FORCSE check before every prescription of a controlled substance for patients 16 or older.

E-Prescribing: Required.

Bottom Line: Florida is viable for insomnia telehealth, but document the psychiatric context clearly. Out-of-state providers can leverage the telehealth registration to serve FL patients. PMHNPs need a collaborating physician.

New York: Progressive NP Laws, Strict PDMP Rules

Licensing: Must hold a New York license. NY is not in the Interstate Medical Licensure Compact, so out-of-state physicians must go through full NY licensure.

NP Scope: Full Practice Authority after 3,600 hours. New York’s NP Modernization Act (permanent as of 2022) requires new NPs to practice under a physician collaborative agreement for 3,600 hours (roughly 2 years full-time). After that, they can practice independently with only ‘collaborative relationships’ (much looser—no formal agreement required).

Experienced PMHNPs in New York can run independent insomnia telehealth practices, prescribing controlled substances without physician oversight.

Telehealth Prescribing: No state restrictions beyond federal rules. New York embraced telehealth for mental health even before COVID. You can establish a patient relationship via video and prescribe controlled substances if the standard of care is met.

PDMP: New York has the strictest PDMP requirement among our focus states. Providers must check the I-STOP PDMP every time they prescribe a Schedule II, III, or IV controlled substance. Every new prescription, every refill—mandatory check.

E-Prescribing: Required for all prescriptions (with very limited exceptions).

Bottom Line: New York is telehealth-friendly and increasingly NP-friendly. The PDMP requirement adds administrative overhead, but integration into most EHR systems makes it manageable. For experienced PMHNPs, NY offers genuine independence.

Pennsylvania: NP Collaboration Required, PDMP Checks for Benzos

Licensing: Pennsylvania is in the Interstate Medical Licensure Compact (physicians). APRNs need a PA license (no APRN compact).

NP Scope: Reduced practice. PMHNPs must have a collaborative agreement with a physician to prescribe. No independent NP practice in Pennsylvania (legislative efforts to grant FPA have failed so far).

The collaboration agreement must specify prescriptive authority, and the physician must review a portion of the NP’s charts periodically. In practice, the physician doesn’t co-sign every script or see every patient, but they’re legally responsible for oversight.

Telehealth Prescribing: Pennsylvania has no comprehensive telehealth statute (a 2020 bill was vetoed). Instead, the state operates under medical/nursing board guidance that allows telehealth if the standard of care is met.

For controlled substances, PA defers to federal rules (currently the DEA extensions). You can prescribe insomnia medications via telehealth as long as you conduct an appropriate evaluation.

PDMP: Pennsylvania’s ABC-MAP Act (Act 191 of 2014) requires PDMP checks before prescribing any opioid or benzodiazepine to a patient—and for every subsequent prescription or refill. This is one of the strictest PDMP laws nationally.

For insomnia, if you prescribe a benzodiazepine (temazepam, triazolam), you must check the PDMP every time. For non-benzo hypnotics like zolpidem, the law doesn’t technically mandate checks—but best practice is to check for all controlled substances.

E-Prescribing: Strongly encouraged, effectively required in most healthcare systems.

Bottom Line: Pennsylvania is workable but requires NP-physician collaboration. The PDMP requirement for benzos adds admin time—factor this into your workflow. Psychiatrists have full scope; PMHNPs need a collaborating MD on record.

Illinois: NP Full Practice Authority, Telehealth Embraced

Licensing: Illinois is in the Interstate Medical Licensure Compact (physicians). APRNs need an Illinois license (no APRN compact yet).

NP Scope: Full Practice Authority after 4,000 hours of practice and additional training. Illinois implemented FPA for APRNs in 2018, allowing experienced NPs to practice and prescribe independently—including controlled substances.

PMHNPs with FPA can run solo insomnia practices in Illinois. Newer NPs without FPA need a written collaborative agreement with a physician (similar to PA model).

Telehealth Prescribing: Illinois has no state restrictions on telehealth prescribing of controlled substances. The Telehealth Act (updated 2021) ensures parity and allows audio-only mental health services in some cases.

You can establish a patient relationship via telehealth and prescribe Schedule IV insomnia medications if clinically appropriate.

PDMP: Illinois mandates PDMP checks before prescribing opioids (since 2018, per PA 100-0564). The requirement is less strict for other controlled substances, but most providers check for all Schedule II–IV prescriptions as best practice.

E-Prescribing: Mandated for controlled substances in line with federal Medicare requirements (effectively required by 2023).

Bottom Line: Illinois is one of the most progressive states for both telehealth and NP practice. FPA-credentialed PMHNPs can operate independently. Chicago and suburbs have high provider density, but downstate Illinois (rural areas) desperately need telehealth insomnia services—opportunity is there.

The Economics of Telehealth Insomnia Care: Why Platforms Like Klarity Make Sense

Let’s talk business reality. As a provider, you have three basic options for building a telehealth insomnia practice:

Option 1: DIY Marketing (SEO, Google Ads, Directories)

Realistic costs:

• SEO: 6–12 months of investment before meaningful patient flow, typically $2,000–5,000/month for agency/consultant work, content creation, and technical optimization
• Google Ads: $15–40+ per click for mental health keywords. Conversion rates vary wildly (many clicks don’t book), so realistic cost per booked patient is $200–400+
• Directory listings (Psychology Today, Zocdoc): Monthly fees ($30–150/month per directory) plus variable per-booking fees ($35–100 on Zocdoc). You compete with hundreds of other providers on the same page.

Hidden costs:

• Staff time handling and qualifying leads (many no-shows from cold traffic)
• Failed campaigns before you find what works
• Ongoing optimization and testing
• Months of cash burn before ROI

Total: Expect to spend $3,000–5,000/month on marketing with uncertain results for at least 6–12 months. For a solo provider or small practice, this is a significant gamble.

Who it works for: Established practices with marketing budgets and patience. If you have the expertise (or hire it) and can wait for SEO to mature, DIY can eventually be cost-effective. But most providers starting out or scaling don’t have this luxury.

Option 2: Traditional Employed Model

Work for a telehealth company as a W-2 employee. They handle marketing, patient acquisition, scheduling, billing, and compliance. You see patients and get paid a salary or per-session rate.

Pros: Predictable income, no upfront costs, no marketing headaches.

Cons: Lower earning potential (employer captures most revenue), less autonomy, fixed schedule.

Option 3: Pay-Per-Appointment Platforms (e.g., Klarity Health)

This is the smart middle ground. Here’s how it works:

• No upfront marketing spend or monthly subscription fees
• No wasted ad spend on clicks that don’t convert
• The platform handles patient acquisition, matching, scheduling, and telehealth infrastructure
• You get pre-qualified patients already matched to your specialty and availability
• You control your schedule—accept or decline patients as you see fit
• You only pay when a qualified patient books with you (standard listing fee per new patient lead, similar to Zocdoc’s model)

Why this makes economic sense:

Instead of gambling $3,000–5,000/month on marketing with no guaranteed results, you pay only when a patient actually shows up. That’s guaranteed ROI vs. speculative ad spend.

The platform’s patient acquisition cost is baked into the listing fee, but they’re doing this at scale (spreading acquisition costs across hundreds of providers). You’d never achieve their efficiency solo—especially starting out.

For insomnia specifically: Platforms like Klarity offer both insurance and cash-pay patient flow. Many insomnia patients prefer telehealth (convenience, stigma reduction), and Klarity pre-screens for your state licensure, specialty, and availability. You’re not wasting time on leads who can’t legally see you or aren’t a clinical fit.

Built-in infrastructure: No need to pay separately for a HIPAA-compliant telehealth platform, EHR integration, or billing support. It’s all included.

Flexibility: Unlike employment, you control your hours. Want to see 10 patients/week? 30? You decide. Need to take a month off? Just adjust your availability.

The Real Comparison

Bottom line: For most psychiatrists and PMHNPs—especially those building or scaling—a pay-per-appointment model removes the financial risk entirely. You’re not betting on SEO or PPC performing. You’re paying for results (booked patients), not hope (traffic that might convert).

Practical Steps to Start Prescribing Insomnia Meds via Telehealth

1. Get Licensed in Your Target States

If you want to serve patients in California, Texas, and Florida, you need licenses in all three states. For physicians, the Interstate Medical Licensure Compact (IMLC) can expedite this in participating states (Texas, Pennsylvania, Illinois—but not California, New York, or Florida).

For NPs, there’s no active APRN compact yet. You’ll need individual state licenses or, in Florida’s case, out-of-state telehealth registration.

2. Obtain DEA and State Controlled Substance Registrations

You need a DEA registration in each state where you prescribe controlled substances. Some states also require a separate state CS license (e.g., Illinois issues an ICS number; California requires registration with the DEA and state AG).

3. Set Up PDMP Access

Register for each state’s PDMP system:

• California: CURES
• Texas: PMP AWARxE
• Florida: E-FORCSE
• New York: I-STOP
• Pennsylvania: ABC-MAP
• Illinois: PMPnow

Most integrate with EHR systems now, but you’ll need credentials and training.

4. Implement Electronic Prescribing for Controlled Substances (EPCS)

Almost every state now requires EPCS for controlled substances. You’ll need:

• An EPCS-certified EHR or e-prescribing platform
• Two-factor authentication (usually a token or app)
• Identity proofing (one-time verification process)

Many telehealth platforms (including Klarity) have EPCS built in.

5. Understand Your Scope and Collaboration Requirements

• Psychiatrists: You’re good to go in any state you’re licensed in.
• PMHNPs in Full Practice states (NY, IL, CA if qualified): Ensure you meet experience thresholds and have the correct licensure/certification for independent practice.
• PMHNPs in Reduced/Restricted states (PA, TX, FL): Secure a collaborative agreement with a physician. If you’re joining a platform like Klarity, this is typically handled for you.

6. Document, Document, Document

Every telehealth insomnia visit should include:

• Sleep history: Duration, severity, patterns, triggers
• Medical screening: Rule out sleep apnea, restless legs, medication side effects, substance use
• Psychiatric assessment: Anxiety, depression, trauma (common insomnia comorbidities)
• Prior treatments: What’s been tried (behavioral, OTC, prescriptions)
• Patient education: Sleep hygiene, risks of medication, plan for follow-up
• Clinical rationale: Why you chose this medication and dose

7. Follow Up Appropriately

Insomnia meds (especially controlled substances) aren’t meant to be indefinite. Schedule follow-ups to:

• Assess efficacy and side effects
• Re-evaluate for underlying causes
• Taper if possible or adjust treatment
• Check PDMP at regular intervals (some states require this for every refill)

Common Questions

Q: Can I prescribe Ambien to a new patient I’ve never met in person?

A: Yes, under current federal rules (through December 31, 2026). You must conduct a thorough telehealth evaluation via live video (audio-video preferred, though audio-only is allowed for certain addiction treatments). State law must also permit it—check the state-specific rules above. Document the visit like you would an in-person consult.

Q: Do I need to check the PDMP every time I refill a benzodiazepine for insomnia?

A: Depends on the state:

• Pennsylvania and Texas: Yes, for every benzo prescription (new or refill).
• New York: Yes, for every Schedule II–IV prescription.
• California: Before the first prescription, then at least every 4 months.
• Florida: Before every controlled substance prescription for patients 16+.
• Illinois: Required for opioids; best practice for all controlled substances.

When in doubt, check every time. It takes seconds with EHR integration and protects you from liability.

Q: What if my state has a ‘chronic pain’ telehealth ban—does that affect insomnia?

A: No. Texas prohibits telehealth prescribing of controlled substances for chronic pain management, but insomnia is not pain. As long as you’re documenting treatment for a sleep disorder (not pain), you’re compliant.

Q: Can PMHNPs prescribe insomnia medications independently in Texas?

A: Not independently, but yes with physician delegation. Texas NPs must have a Prescriptive Authority Agreement with a supervising physician. They can prescribe Schedule III–V controlled substances (including insomnia meds) under that agreement, but cannot prescribe Schedule II in outpatient settings.

Q: I’m a psychiatrist in California. Can I prescribe Adderall via telehealth for a patient with ADHD and insomnia?

A: Adderall (Schedule II stimulant) for ADHD is technically allowed under current federal DEA extensions, but California has unofficial guidance discouraging Schedule II prescribing via telehealth without an in-person exam. For ADHD, many CA psychiatrists do an initial in-person visit (or document why telehealth meets the standard of care) before prescribing stimulants. For the insomnia component, Schedule IV sleep meds are fine via telehealth.

Q: What happens when the DEA extension expires at the end of 2026?

A: The DEA is expected to finalize permanent telehealth prescribing rules before then (likely involving special registrations). If you’re practicing telehealth insomnia care, stay tuned for DEA announcements and be prepared to apply for a Telemedicine Special Registration if required.

Q: How do I handle a patient in Florida who’s traveling to New York—can I continue prescribing?

A: You must be licensed in the state where the patient is physically located at the time of the telehealth visit. If your patient travels to New York and you only hold a Florida license, you cannot legally treat them while they’re in NY. They’d need to see a NY-licensed provider or wait until they return to Florida.

Q: Can I use audio-only (phone) for insomnia telehealth visits?

A: Federal rules currently allow audio-only for certain addiction treatment prescribing (buprenorphine). For general controlled substance prescribing (insomnia), live audio-video is preferred and explicitly allowed under the DEA extension. Some states and insurers may have stricter requirements for video. Check your state’s telehealth law—many require video for initial controlled substance prescriptions.

Why This Matters for Your Practice

Telehealth insomnia care is legal, scalable, and in high demand. The regulatory landscape is complex but navigable if you understand the rules:

• Federal DEA extensions give you the green light through 2026 (and likely permanent rules will preserve much of this flexibility).
• State laws vary dramatically—know your scope, licensure requirements, PDMP obligations, and any telehealth prescribing restrictions.
• Economics favor platforms that handle patient acquisition and infrastructure. DIY marketing is expensive and risky; pay-per-appointment models let you focus on clinical care while paying only for results.

If you’re a psychiatrist, you have full scope in every state you’re licensed in. If you’re a PMHNP, your autonomy depends on state law—but even in restricted states, collaboration models work well within telehealth companies.

The patients are there. Insomnia affects 30% of adults at any given time, and most don’t get specialized care. Telehealth removes barriers—for patients and providers.

The question isn’t whether you can do this. It’s whether you’re positioned to do it compliantly and profitably.

Ready to Start?

Klarity Health connects psychiatrists and PMHNPs with pre-qualified insomnia patients via telehealth—no upfront marketing costs, no wasted ad spend, just a steady flow of patients matched to your availability and scope. We handle licensing verification, PDMP integration, EPCS-enabled prescribing, and all the infrastructure headaches.

You see patients. We handle the rest. And you only pay when a patient books.

Explore Klarity’s Provider Network →

Sources and References

1. DEA Press Release – ‘DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care’ (December 31, 2025). Official announcement of the Fourth Temporary Rule extending telehealth prescribing of controlled substances through December 31, 2026. dea.gov

2. DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access’ (January 16, 2025). Details on proposed permanent telehealth prescribing framework, including Special Registration and Advanced Registration pathways. dea.gov

3. Florida Statutes §456.47 – Use of Telehealth to Provide Services. Official state law defining telehealth practice standards and controlled substance prescribing restrictions (psychiatric disorder exception). leg.state.fl.us

4. Florida Statutes §464.012 – Nursing Practice Act, APRN Scope and Prescri

Source:

• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=WASHINGTON%20%E2%80%93%C2%A0The%20U,flexibilities%20through%20December%2031%2C%202026
• https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care#:~:text=Under%20these%20telemedicine%20flexibilities%2C%20DEA,applicable%20federal%20and%20state%20law
• https://www.healthcarefinancenews.com/news/telehealth-prescribing-controlled-drugs-extended-through-2025#:~:text=During%20the%20COVID,person%20evaluation%20of%20that%20patient
• https://www.dlapiper.com/en-th/insights/publications/2024/11/dea-and-hhs-issue-third-temporary-extension-of-telemedicine-flexibilities#:~:text=Further%2C%20as%20the%20Third%20Temporary,monitor%20this%20space%20for%20updates
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=ever%20having%20an%20in,specialized%20medical%20providers%20to%20issue
• https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements#:~:text=New%20York%20State%20Education%20Law,to%20practice%20under%20physician%20supervision
• https://idfpr.illinois.gov/profs/nursing.html#:~:text=,APN%20Controlled%20Substance
• https://www.op.nysed.gov/professions/nurse-practitioners/professional-practice/practice-requirements#:~:text=Nurse%20practitioners%2C%20however%2C%20must%20practice,or%20certified%20NP%20as%20follows
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=also%20are%20psychiatric%20nurses%20as,455
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=provider%20may%20not%20use%20telehealth,in%20Schedule%20II%20of%20s